Previously doing business as Molecular Imaging, Molecular Imaging Research is a specialty contract research organization (CRO) providing in vivo preclinical imaging services. With a proven track record of imaging and drug discovery expertise, the company enhances preclinical and translational research through its in vivo pharmaco-IMAGING platform. This combination of traditional pharmacology and innovative imaging includes MRI, micro-CT, micro-PET, SPECT and optical (bioluminescence and fluorescence molecular tomography) tools to quantitatively measure response to therapy at anatomical, functional and molecular levels. Molecular Imaging also provides supportive in vitro services. We have performed over 2000 cell line based traditional oncology studies and over 500 imaging enhanced studies since the firm was established.
